The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization
Abstract
Computer visualization techniques were used to map the distribution of dopaminergic neurons within midbrain tissue sections from 5 parkinsonian patients and 3 age‐matched control subjects. The Parkinsonian brains had over 50% fewer dopaminergic neurons within the midbrain than age‐matched normal brains. The cell loss occurred within the combined substantia nigra (dopaminergic nucleus A9) and retrorubral (dopaminergic nucleus A8) areas (> 61%) and the ventral tegmental area (dopaminergic nucleus A10) (> 42%). The cell loss was greatest within the ventral portion of the substantia nigra zona compacta. The specific pattern of cell loss is very similar to the pattern of cells that project to the striatum (as opposed to cortical and limbic sites) in animal neuroanatomical tracing experiments. These data suggest that Parkinson's disease preferentially destroys midbrain dopaminergic neurons in nuclei A8, A9, and A10, which project to the striatum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Estimation of nuclear population from microtome sections
Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Fallon, J. H., & Moore, R. Y. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901800310 · Cited by 1,169
Central Catecholamine Neuron Systems: Anatomy and Physiology of the Dopamine Systems
Moore, R. Y., & Bloom, F. E. (1978) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.01.030178.001021 · Cited by 926
Scatton, B., Javoy-Agid, F., Rouquier, L., Dubois, B., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90993-9 · Cited by 726
HENN, F. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.12.1633-b · Cited by 506
Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to Neuromelanin
D'Amato, R. J., Lipman, Z. P., & Snyder, S. H. (1986) · Science · doi:10.1126/science.3080808 · Cited by 296
Hallman, H., Lange, L., Olson, L., Strömberg, I., & Jonsson, G. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07120.x · Cited by 281
Saper, C. B., Wainer, B. H., & German, D. C. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90063-7 · Cited by 239
Self-citationUhl, G. R., Hedreen, J. C., & Price, D. L. (1985) · Neurology · doi:10.1212/wnl.35.8.1215 · Cited by 230
On the origin and significance of neuromelanin.
Dg, G. (1979) · PubMed · Cited by 223
The human locus coeruleus: computer reconstruction of cellular distribution
German, D., Walker, B., Manaye, K., Smith, W., Woodward, D., & North, A. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-05-01776.1988 · Cited by 208
Self-citationFallon, J. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-12-01361.1981 · Cited by 206
Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex
German, D. C., White, C. L., & Sparkman, D. R. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90123-0 · Cited by 203
Self-citationGerman, D. C., Dubach, M., Askari, S., Speciale, S. G., & Bowden, D. M. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90320-x · Cited by 200
Self-citationBogerts, B., Häntsch, J., & Herzer, M. (1983) · PubMed · Cited by 197
A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker
Bogerts, B. (1981) · Journal of Comparative Neurology · doi:10.1002/cne.901970106 · Cited by 177
Monoamine innervation of the forebrain: Collateralization
Fallon, J. H., & Loughlin, S. E. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90143-5 · Cited by 169
The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis
Fibiger, H. C. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100046230 · Cited by 144
Organization of the ascending striatal afferents in monkeys
Szabo, J. (1980) · The Journal of Comparative Neurology · doi:10.1002/cne.901890207 · Cited by 138
German, D. C., Schlusselberg, D. S., & Woodward, D. J. (1983) · Journal of Neural Transmission · doi:10.1007/bf01248996 · Cited by 125
Self-citationCORRESPONDENCE OF MELANIN-PIGMENTED NEURONS IN HUMAN BRAIN WITH A1–A14 CATECHOLAMINE CELL ROUPS
SAPER, C. B., & PETITO, C. K. (1982) · Brain · doi:10.1093/brain/105.1.87 · Cited by 107
Self-citationTanaka, C., Ishikawa, M., & Shimada, S. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90139-3 · Cited by 70
Cited by
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway
Deumens, R., Blokland, A., & Prickaerts, J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7891 · Cited by 758
Duty, S., & Jenner, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 753
Pathology of Parkinson’s disease: Changes other than the nigrostriatal pathway
Jellinger, K. A. (1991) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159935 · Cited by 684
Metadata
- Authors
- German, D. C., Manaye, K., Smith, W. K., Woodward, D. J., & Saper, C. B.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1989-10
- Volume
- 26
- Issue
- 4
- Pages
- 507-514
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2030187260
- Cited by
- 396
- References
- 25
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.